News

Treatment of acute hepatitis C infection (HCV) in HIV-positive individuals

In a multicenter ACTG-study, 27 HIV-positive men with acute hepatitis C were treated with Ledipasvir/Sofosbuvir for 8 weeks. Read more

Entecavir versus tenofovir

The cumulative probabilities of hepatocellular carcinoma (HCC), death, or liver transplant were studied in 2,897 treatment- naïve patients with hepatitis B who started treatment with either entecavir (ETV) or tenofovir deoxyfumarate (TDF) between 2012 and 2014. Read more

Magazine